Triple therapy fights type 2 diabetes without weight gain
Researchers have found that triple therapy using insulin, metformin, and a thiazolidinedione drug can control blood sugar levels without weight gain. The study showed that nearly all patients reduced their HbAlc levels below 7 percent, with some even achieving levels below 6 percent.